Urinary Cannabinoid Detection Times after Controlled Oral Administration of Δ9-Tetrahydrocannabinol to Humans
Author(s) -
Richard A. Gustafson,
Barry Levine,
Peter Stout,
K. L. Klette,
Maya George,
Eric T. Moolchan,
Marilyn A. Huestis
Publication year - 2003
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/49.7.1114
Subject(s) - cannabinoid , tetrahydrocannabinol , urinary system , δ9 tetrahydrocannabinol , cannabis , medicine , oral administration , pharmacology , psychiatry , receptor
Urinary cannabinoid excretion and immunoassay performance were evaluated by semiquantitative immunoassay and gas chromatography-mass spectrometry (GC/MS) analysis of metabolite concentrations in 4381 urine specimens collected before, during, and after controlled oral administration of tetrahydrocannabinol (THC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom